Back to Search
Start Over
Fibrate therapy and flow-mediated dilation: A systematic review and meta-analysis of randomized placebo-controlled trials.
- Source :
-
Pharmacological research [Pharmacol Res] 2016 Sep; Vol. 111, pp. 163-179. Date of Electronic Publication: 2016 Jun 15. - Publication Year :
- 2016
-
Abstract
- Flow-mediated dilation (FMD) of the brachial artery reflects endothelium-dependent vasodilator function; since it correlates with coronary endothelial function, its reduction could predict cardiovascular events. Several studies have investigated the potential impact of fibrates therapy on endothelial function, but clinical findings have not been fully consistent. We aimed to conduct a meta-analysis of randomized placebo-controlled trials in order to clarify whether fibrate therapy could improve endothelial function. A systematic search in PubMed-Medline, SCOPUS, Web of Science and Google Scholar databases was performed to identify randomized placebo-controlled trials investigating the effect of fibrates on endothelial function as estimated by FMD. A random-effects model and generic inverse variance method were used for meta-analysis. Sensitivity analysis, risk of bias evaluation, and publication bias assessment were carried out using standard methods. Random-effects meta-regression was used to evaluate the impact of treatment duration on the estimated effect size. Fifteen trials with a total of 556 subjects met the eligibility criteria. Fibrate therapy significantly improves FMD (weighted mean difference [WMD]: 1.64%, 95% CI: 1.15, 2.13, p<0.001) and the result was confirmed in both subgroups with treatment durations ≤8 weeks (WMD: 1.35%, 95% CI: 0.85, 1.86, p<0.001) and >8 weeks (WMD: 2.55%, 95% CI: 1.21, 3.89, p<0.001). When the analysis was stratified according to the fibrate type, a significant effect was observed with fenofibrate but not with gemfibrozil, though difference between the two subgroups was not significant. Meta-analysis of data from trials where nitrate mediated dilation (NMD) was available did not suggest a significant change in NMD following treatment with fibrates. The results of this meta-analysis suggest that fibrates may exert beneficial effects on endothelial function, even over a short-term treatment course.<br /> (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Subjects :
- Blood Flow Velocity
Brachial Artery physiopathology
Cardiovascular Diseases etiology
Cardiovascular Diseases physiopathology
Dyslipidemias blood
Dyslipidemias complications
Endothelium, Vascular physiopathology
Fibric Acids adverse effects
Humans
Hypolipidemic Agents adverse effects
Randomized Controlled Trials as Topic
Regional Blood Flow
Risk Factors
Time Factors
Treatment Outcome
Vasodilator Agents adverse effects
Brachial Artery drug effects
Cardiovascular Diseases prevention & control
Dyslipidemias drug therapy
Endothelium, Vascular drug effects
Fibric Acids therapeutic use
Hypolipidemic Agents therapeutic use
Vasodilation drug effects
Vasodilator Agents therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1096-1186
- Volume :
- 111
- Database :
- MEDLINE
- Journal :
- Pharmacological research
- Publication Type :
- Academic Journal
- Accession number :
- 27320045
- Full Text :
- https://doi.org/10.1016/j.phrs.2016.06.011